petri dish

Providing the project management expertise to help Imperial's academics successfully lead high profile, EU funded initiatives.

The Research Project Management team provide Imperial's academics with a range of programme and project management services including:

  • Consortium management
  • Horizon 2020 proposals
  • Risk management
  • Budget and resource management
  • Co-ordination and reporting
  • Research impact
  • Exploitation, dissemination and communication
  • Liason with EC and project partners

Our current projects

EAVI 2020

eavi2020

EAVI2020 is a 23 million euro initiative to accelerate the search for an effective HIV vaccine - running from 2015 to 2020.

The EAVI2020 consortium, which is led by Prof Robin Shattock from Imperial College London, brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA, pooling their knowledge and expertise to develop novel candidate vaccines that can be taken through to human trials within five years. EAVI2020 is funded with an EU-grant under the health program of Horizon 2020 for research and innovation.

The Research Project Management team provide consortium management to the 23 partner institutions and leads on the project’s dissemination, communication and impact activities.

To keep up to date with EAVI2020, you can visit the project's website, or follow our work on Twitter, EAVI2020 facebook and Linkedin.


EAVI2020 News

PhD students in a classroom for the 7th PhD training courseFrom Lab to Clinic: 7th PhD training course in Vienna a success

Patient receiving trial drug via injection

EAVI2020 Announces Start of New HIV Vaccine Trial

EDEN 2020

EDEN 2020 logo

The Enhanced Delivery Ecosystem for Neurosurgery (EDEN2020) is an €8.3 million project (2016-2020) funded by the European Union Horizon2020 programme, which aims to translate the latest surgical robotic technologies into patient-specific neurosurgical applications, meeting the demand for better and less invasive treatment in neurosurgery. The EDEN2020 consortium was awarded this competitive Research and Innovation Action (RIA) on robotic-assisted neurosurgical drug delivery in April 2016.

The Imperial team, headed by Prof. Rodriguez y Baena, coordinates EDEN2020, which also benefits from strong industrial presence (Renishaw plc. and XoGraph ltd.), a first class clinical team in Italy (Universita’ di Milano, San Raffaele and Politecnico di Milano) led by Prof. Lorenzo Bello, and the involvement of leading experts in intra-operative imaging (Technical University of Munich) and shape sensing (Universitair Medisch Centrum Groningen).

The Research Project Management team provides consortium management to the 8 industrial and academic partners from the UK, Italy, the Netherlands and Germany. We also lead dissemination, communication and exploitation activities.

For further information please visit our eden2020.eu website, facebook pagestwitter and LinkedIn.

EDEN2020 News


Dr Marta Archanco talking to students from the Generating Genius programme about the research projects currently undertaken by the Research Project Management OfficeGenerating future STEM Leaders

EDEN2020 engineers talking to the general public about the EDEN2020 project at the Natural History Museum event, NHM LatesWhat do a wasp, a brain and cancer treatment have in common? The stinger of course!

How it Works

PRESTIGE-AF

PREvention of Stroke in Intracerebral hermorrhaGE survivor with Atrial Fibrillation

PRESTIGE-AF is a €7 million European Commission funded project (2017-2022) that brings together scientists and clinicians across Europe to reduce the risk of Stroke in patients.

PRESTIGE-AF addresses the unmet need of best antithrombotic stroke prevention in Intracerebral haemorrhage (ICH) patients with atrial fibrillation (AF). Recurrent stroke reduces individual life expectancy, quality of life and has high public health impact. The project’s consortium will generate new tools to tailor prevention.

The project is led by  Professor Roland Veltkamp from the Department of Medicine at Imperial College London and involves 11 other partner institutions throughout the UK and across Europe including Denmark, Germany and France. The consortium members will work collaboratively within the European Commission framework to deliver the desired outcomes over 5 years.

The Research Project Management team is providing the Consortium Management for the project as well as dissemination, communication and exploitation management.

To keep up to date, visit the PRESTIGE-AF website and follow us on twitter.

PRESTIGE-AF News

poster of the ESOC conference with event detailsPRESTIGE-AF going to ESOC 2019

 

PERFORM

PerFORM

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union

PERFORM is an €18 million collaborative project (2016-2020) funded under the European Commission’s Horizon 2020 programme for research and innovation.

The project is looking at ways to reduce antibiotic misuse, through the development of improved tests used to distinguish bacterial from viral infections. Currently, doctors have very limited capacity to reliably differentiate life-threatening bacterial infections from trivial viral illnesses in children. As a result, thousands of children worldwide undergo investigations such as lumbar punctures, x-rays and blood cultures, and are treated with broad spectrum antibiotics while waiting to rule out bacterial infection.

The project is led by Professor Michael Levin from Imperial College and involves partners in Oxford, Liverpool, Spain, Austria, Germany, the Netherlands, Greece, Slovenia, Latvia and Switzerland, along with two biotechnology companies (Micropathology Ltd in the UK and bioMérieux in France). The Research Project Management team is providing overall consortium management, as well as dissemination and stakeholder engagement.

More information can be found on the PERFORM2020 website and Twitter

Prof. Michael Levin, lead PI and Professor of International Child Health says...

“Better tests to identify those children with life threatening infection amongst the infinitely more numerous children with viral infections are urgently needed if antibiotic use is to be reduced. We have exciting pilot data which shows that bacterial infection can be recognised by the patterns of genes and proteins switched on in each child’s blood during infection. PERFORM will apply sophisticated genomic and proteomic methods to study thousands of febrile children with the aim of identifying and developing a better test for bacterial infection than what is currently available.”

PERFORM News

Not goodbye, just a ‘see you next year’

KIOS Teaming Project

The KIOS Teaming Project is a collaborative initiative funded by the European Commission’s Teaming Programme. The project is led by the KIOS Research and Innovation Centre of Excellence based at the University of Cyprus in collaboration with Imperial College London.

The mission of the KIOS Research and Innovation Centre of Excellence is to conduct multidisciplinary research and innovation in the area of Information and Communication Technologies (ICT) with emphasis on the Monitoring, Control, Security and Management of Critical Infrastructures, which include large-scale, complex systems such as power and energy systems, water systems, transportation systems, telecommunication networks and emergency management and response systems. The total value of the European Commission award is €15million and the project will run from 2017 to 2024.

The Imperial team is led by Professor Thomas Parisini from the Department of Electrical and Electronic Engineering and provides academic expertise in cyber-security and power and control systems. The Research Project Management team is providing expertise on dissemination, exploitation and communication activities, innovation management, data management and organisational transformation.

KIOS CoE Latest News